Tag: OTCQX:MEDIF

August 13, 2019

MediPharm Labs Reports Strong, Profitable Second Quarter Results

Q2 2019 Revenue of $31.5 Million, Adjusted EBITDA of $7.7 Million, Net Income before tax of $4.1 Million
August 1, 2019

MediPharm Labs Sets Date to Announce Second Quarter 2019 Financial Results

MediPharm Labs Corp. (TSX:LABS, OTCQX:MEDIF, FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation,...
July 18, 2019

MediPharm Labs Conditionally Approved to Graduate to the TSX

MediPharm Labs Corp. (TSXV:LABS) (OTCQX:MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation,...
July 16, 2019

MediPharm Labs Provides Operational Update and Increases Average Weekly Production of Active Cannabinoid Component to 75 Million Milligrams

MediPharm Labs Corp. (TSXV:LABS, OTCQX:MEDIF, FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation,...
June 17, 2019

MediPharm Labs Announces Closing of $75 Million Bought Deal Financing

MediPharm Labs Corp. (TSXV:LABS) (OTCQX:MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”), a leader in specialized, research-driven cannabis extraction and cannabinoid isolation,...
May 29, 2019

MediPharm Labs Announces $60 Million Bought Deal Equity Financing

MediPharm Labs Corp. (TSXV:LABS, OTCQX:MEDIF, FSE:MLZ)(“MediPharm Labs” or the “Company”), a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, is pleased to...
May 29, 2019

MediPharm Labs Corp. Announces Upsize of Bought Deal Financing to $75 Million

MediPharm Labs Corp. (TSXV:LABS, OTCQX:MEDIF, FSE:MLZ) (“MediPharm Labs” or the “Company”), a leader in specialized, research-driven cannabis extraction and cannabinoid...